CMS Reviewing Medicare Payments for Dialysis Drugs
CMS is reviewing its Medicare reimbursements to hospitals and clinics that use certain drugs for dialysis treatment, after a recent Government Accountability Office report found that the program could be overpaying for the drugs by as much as $880 million annually. CMS is expected to propose a new pricing scheme in June and finalize it in November, before it takes effect in 2014.
- "Medicare To Adjust Payment for Dialysis Drugs After Overspending Millions" (Whoriskey, Washington Post, 1/30).